WealthTrust Axiom’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Hold
1,383
0.06% 242
2026
Q1
$273K Hold
1,383
0.07% 222
2025
Q4
$254K Hold
1,383
0.07% 221
2025
Q3
$212K Buy
+1,383
New +$209K 0.06% 240
2017
Q3
Sell
-2,941
Closed -$200K 218
2017
Q2
$200K Sell
2,941
-500
-15% -$32.7K 0.08% 202
2017
Q1
$214K Buy
+3,441
New +$200K 0.08% 199
2016
Q4
Sell
-3,441
Closed -$226K 229
2016
Q3
$226K Sell
3,441
-125
-4% -$8.17K 0.08% 185
2016
Q2
$215K Hold
3,566
0.08% 184
2016
Q1
$200K Hold
3,566
0.08% 186
2015
Q4
$242K Buy
3,566
+250
+8% +$16.4K 0.1% 164
2015
Q3
$211K Sell
3,316
-450
-12% -$29.6K 0.09% 180
2015
Q2
$239K Sell
3,766
-300
-7% -$20.5K 0.09% 177
2015
Q1
$278K Sell
4,066
-95
-2% -$6.6K 0.1% 157
2014
Q4
$292K Sell
4,161
-150
-3% -$10.7K 0.1% 155
2014
Q3
$307K Hold
4,311
0.11% 144
2014
Q2
$320K Sell
4,311
-1,000
-19% -$72.3K 0.11% 138
2014
Q1
$344K Sell
5,311
-499
-9% -$32.2K 0.12% 123
2013
Q4
$344K Buy
5,810
+416
+8% +$22.6K 0.13% 112
2013
Q3
$280K Sell
5,394
-800
-13% -$40.2K 0.12% 125
2013
Q2
$292K Buy
+6,194
New +$315K 0.13% 122

Other funds holding AZN

WealthTrust Axiom's AZN Position: Q2 2026 in Review

WealthTrust Axiom held its AstraZeneca (AZN) position steady in Q2 2026 at 1,383 shares worth $262K. The position accounts for 0.06% of the portfolio, ranked #242.

WealthTrust Axiom first reported a position in AZN in Q2 2013 and has held it in 20 quarters since. The position peaked at $344K in Q1 2014. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • WealthTrust Axiom held 1,383 shares of AstraZeneca worth $262K as of Q2 2026.
  • WealthTrust Axiom left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.06% of WealthTrust Axiom's portfolio in Q2 2026, its #242 holding.
  • WealthTrust Axiom first reported a position in AstraZeneca in Q2 2013 and has held it in 20 quarters since.
  • WealthTrust Axiom's AstraZeneca position peaked at $344K in Q1 2014.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on WealthTrust Axiom's 13F filing for Q2 2026, filed 11 Aug 2026.